 | • レポートコード：QYR2104Z5004 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、呼吸器疾患治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、鼻、注射剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・呼吸器疾患治療薬の市場動向 ・企業の競争状況、市場シェア ・呼吸器疾患治療薬の種類別市場規模（経口、鼻、注射剤） ・呼吸器疾患治療薬の用途別市場規模（病院、小売薬局） ・呼吸器疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・呼吸器疾患治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・呼吸器疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・呼吸器疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・呼吸器疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Sanofi、Teva Pharmaceutical、Merck & Co.、Sumitomo Dainippon Pharma、Mylan、AstraZeneca、Boehringer Ingelheim International、Vertex Pharmaceuticals Incorporated、Roche、GlaxoSmithKline） ・結論 |
Market Analysis and Insights: Global Respiratory Disorders Drugs Market
The global Respiratory Disorders Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Disorders Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Disorders Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Disorders Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Disorders Drugs market.
Global Respiratory Disorders Drugs Scope and Market Size
Respiratory Disorders Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Disorders Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Nasal
Injectable
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Sanofi
Teva Pharmaceutical
Merck & Co.
Sumitomo Dainippon Pharma
Mylan
AstraZeneca
Boehringer Ingelheim International
Vertex Pharmaceuticals Incorporated
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Disorders Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Nasal
1.2.4 Injectable
1.3 Market by Application
1.3.1 Global Respiratory Disorders Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disorders Drugs Market Perspective (2016-2027)
2.2 Respiratory Disorders Drugs Growth Trends by Regions
2.2.1 Respiratory Disorders Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Disorders Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Disorders Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Disorders Drugs Industry Dynamic
2.3.1 Respiratory Disorders Drugs Market Trends
2.3.2 Respiratory Disorders Drugs Market Drivers
2.3.3 Respiratory Disorders Drugs Market Challenges
2.3.4 Respiratory Disorders Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Disorders Drugs Players by Revenue
3.1.1 Global Top Respiratory Disorders Drugs Players by Revenue (2016-2021)
3.1.2 Global Respiratory Disorders Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Disorders Drugs Revenue
3.4 Global Respiratory Disorders Drugs Market Concentration Ratio
3.4.1 Global Respiratory Disorders Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disorders Drugs Revenue in 2020
3.5 Respiratory Disorders Drugs Key Players Head office and Area Served
3.6 Key Players Respiratory Disorders Drugs Product Solution and Service
3.7 Date of Enter into Respiratory Disorders Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Disorders Drugs Breakdown Data by Type
4.1 Global Respiratory Disorders Drugs Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Disorders Drugs Forecasted Market Size by Type (2022-2027)
5 Respiratory Disorders Drugs Breakdown Data by Application
5.1 Global Respiratory Disorders Drugs Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Disorders Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Respiratory Disorders Drugs Market Size (2016-2027)
6.2 North America Respiratory Disorders Drugs Market Size by Type
6.2.1 North America Respiratory Disorders Drugs Market Size by Type (2016-2021)
6.2.2 North America Respiratory Disorders Drugs Market Size by Type (2022-2027)
6.2.3 North America Respiratory Disorders Drugs Market Size by Type (2016-2027)
6.3 North America Respiratory Disorders Drugs Market Size by Application
6.3.1 North America Respiratory Disorders Drugs Market Size by Application (2016-2021)
6.3.2 North America Respiratory Disorders Drugs Market Size by Application (2022-2027)
6.3.3 North America Respiratory Disorders Drugs Market Size by Application (2016-2027)
6.4 North America Respiratory Disorders Drugs Market Size by Country
6.4.1 North America Respiratory Disorders Drugs Market Size by Country (2016-2021)
6.4.2 North America Respiratory Disorders Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Respiratory Disorders Drugs Market Size (2016-2027)
7.2 Europe Respiratory Disorders Drugs Market Size by Type
7.2.1 Europe Respiratory Disorders Drugs Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Disorders Drugs Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Disorders Drugs Market Size by Type (2016-2027)
7.3 Europe Respiratory Disorders Drugs Market Size by Application
7.3.1 Europe Respiratory Disorders Drugs Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Disorders Drugs Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Disorders Drugs Market Size by Application (2016-2027)
7.4 Europe Respiratory Disorders Drugs Market Size by Country
7.4.1 Europe Respiratory Disorders Drugs Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Disorders Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Disorders Drugs Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Type
8.2.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Disorders Drugs Market Size by Application
8.3.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Disorders Drugs Market Size by Region
8.4.1 Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Respiratory Disorders Drugs Market Size (2016-2027)
9.2 Latin America Respiratory Disorders Drugs Market Size by Type
9.2.1 Latin America Respiratory Disorders Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Disorders Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Disorders Drugs Market Size by Type (2016-2027)
9.3 Latin America Respiratory Disorders Drugs Market Size by Application
9.3.1 Latin America Respiratory Disorders Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Disorders Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Disorders Drugs Market Size by Application (2016-2027)
9.4 Latin America Respiratory Disorders Drugs Market Size by Country
9.4.1 Latin America Respiratory Disorders Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Disorders Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Disorders Drugs Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Type
10.2.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Disorders Drugs Market Size by Application
10.3.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Disorders Drugs Market Size by Country
10.4.1 Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Respiratory Disorders Drugs Introduction
11.1.4 Novartis Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Respiratory Disorders Drugs Introduction
11.2.4 Sanofi Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Details
11.3.2 Teva Pharmaceutical Business Overview
11.3.3 Teva Pharmaceutical Respiratory Disorders Drugs Introduction
11.3.4 Teva Pharmaceutical Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.3.5 Teva Pharmaceutical Recent Development
11.4 Merck & Co.
11.4.1 Merck & Co. Company Details
11.4.2 Merck & Co. Business Overview
11.4.3 Merck & Co. Respiratory Disorders Drugs Introduction
11.4.4 Merck & Co. Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.4.5 Merck & Co. Recent Development
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Company Details
11.5.2 Sumitomo Dainippon Pharma Business Overview
11.5.3 Sumitomo Dainippon Pharma Respiratory Disorders Drugs Introduction
11.5.4 Sumitomo Dainippon Pharma Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.5.5 Sumitomo Dainippon Pharma Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Respiratory Disorders Drugs Introduction
11.6.4 Mylan Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Respiratory Disorders Drugs Introduction
11.7.4 AstraZeneca Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Boehringer Ingelheim International
11.8.1 Boehringer Ingelheim International Company Details
11.8.2 Boehringer Ingelheim International Business Overview
11.8.3 Boehringer Ingelheim International Respiratory Disorders Drugs Introduction
11.8.4 Boehringer Ingelheim International Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.8.5 Boehringer Ingelheim International Recent Development
11.9 Vertex Pharmaceuticals Incorporated
11.9.1 Vertex Pharmaceuticals Incorporated Company Details
11.9.2 Vertex Pharmaceuticals Incorporated Business Overview
11.9.3 Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Introduction
11.9.4 Vertex Pharmaceuticals Incorporated Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.9.5 Vertex Pharmaceuticals Incorporated Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Respiratory Disorders Drugs Introduction
11.10.4 Roche Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.10.5 Roche Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Respiratory Disorders Drugs Introduction
11.11.4 GlaxoSmithKline Revenue in Respiratory Disorders Drugs Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Respiratory Disorders Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Nasal
Table 4. Key Players of Injectable
Table 5. Global Respiratory Disorders Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Respiratory Disorders Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Respiratory Disorders Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Respiratory Disorders Drugs Market Share by Regions (2016-2021)
Table 9. Global Respiratory Disorders Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Respiratory Disorders Drugs Market Share by Regions (2022-2027)
Table 11. Respiratory Disorders Drugs Market Trends
Table 12. Respiratory Disorders Drugs Market Drivers
Table 13. Respiratory Disorders Drugs Market Challenges
Table 14. Respiratory Disorders Drugs Market Restraints
Table 15. Global Respiratory Disorders Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Respiratory Disorders Drugs Market Share by Players (2016-2021)
Table 17. Global Top Respiratory Disorders Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disorders Drugs as of 2020)
Table 18. Ranking of Global Top Respiratory Disorders Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Respiratory Disorders Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Respiratory Disorders Drugs Product Solution and Service
Table 22. Date of Enter into Respiratory Disorders Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Respiratory Disorders Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Respiratory Disorders Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Respiratory Disorders Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Respiratory Disorders Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Respiratory Disorders Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Respiratory Disorders Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Respiratory Disorders Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Respiratory Disorders Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Respiratory Disorders Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Respiratory Disorders Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Respiratory Disorders Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Respiratory Disorders Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Respiratory Disorders Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Respiratory Disorders Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Respiratory Disorders Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Respiratory Disorders Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Respiratory Disorders Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Respiratory Disorders Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Respiratory Disorders Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Respiratory Disorders Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Respiratory Disorders Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Respiratory Disorders Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Respiratory Disorders Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Respiratory Disorders Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Respiratory Disorders Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Respiratory Disorders Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Respiratory Disorders Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Respiratory Disorders Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Respiratory Disorders Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Respiratory Disorders Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Respiratory Disorders Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Respiratory Disorders Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Respiratory Disorders Drugs Product
Table 65. Novartis Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Respiratory Disorders Drugs Product
Table 70. Sanofi Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Teva Pharmaceutical Company Details
Table 73. Teva Pharmaceutical Business Overview
Table 74. Teva Pharmaceutical Respiratory Disorders Drugs Product
Table 75. Teva Pharmaceutical Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 76. Teva Pharmaceutical Recent Development
Table 77. Merck & Co. Company Details
Table 78. Merck & Co. Business Overview
Table 79. Merck & Co. Respiratory Disorders Drugs Product
Table 80. Merck & Co. Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 81. Merck & Co. Recent Development
Table 82. Sumitomo Dainippon Pharma Company Details
Table 83. Sumitomo Dainippon Pharma Business Overview
Table 84. Sumitomo Dainippon Pharma Respiratory Disorders Drugs Product
Table 85. Sumitomo Dainippon Pharma Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 86. Sumitomo Dainippon Pharma Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Respiratory Disorders Drugs Product
Table 90. Mylan Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Respiratory Disorders Drugs Product
Table 95. AstraZeneca Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Boehringer Ingelheim International Company Details
Table 98. Boehringer Ingelheim International Business Overview
Table 99. Boehringer Ingelheim International Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 100. Boehringer Ingelheim International Recent Development
Table 101. Vertex Pharmaceuticals Incorporated Company Details
Table 102. Vertex Pharmaceuticals Incorporated Business Overview
Table 103. Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Product
Table 104. Vertex Pharmaceuticals Incorporated Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 105. Vertex Pharmaceuticals Incorporated Recent Development
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Respiratory Disorders Drugs Product
Table 109. Roche Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 110. Roche Recent Development
Table 111. GlaxoSmithKline Company Details
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Respiratory Disorders Drugs Product
Table 114. GlaxoSmithKline Revenue in Respiratory Disorders Drugs Business (2016-2021) & (US$ Million)
Table 115. GlaxoSmithKline Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Disorders Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Nasal Features
Figure 4. Injectable Features
Figure 5. Global Respiratory Disorders Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Respiratory Disorders Drugs Report Years Considered
Figure 9. Global Respiratory Disorders Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Respiratory Disorders Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Respiratory Disorders Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Respiratory Disorders Drugs Market Share by Regions (2022-2027)
Figure 13. Global Respiratory Disorders Drugs Market Share by Players in 2020
Figure 14. Global Top Respiratory Disorders Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disorders Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Respiratory Disorders Drugs Revenue in 2020
Figure 16. Global Respiratory Disorders Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Respiratory Disorders Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Respiratory Disorders Drugs Market Share by Type (2016-2027)
Figure 20. North America Respiratory Disorders Drugs Market Share by Application (2016-2027)
Figure 21. North America Respiratory Disorders Drugs Market Share by Country (2016-2027)
Figure 22. United States Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Respiratory Disorders Drugs Market Share by Type (2016-2027)
Figure 26. Europe Respiratory Disorders Drugs Market Share by Application (2016-2027)
Figure 27. Europe Respiratory Disorders Drugs Market Share by Country (2016-2027)
Figure 28. Germany Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Respiratory Disorders Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Respiratory Disorders Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Respiratory Disorders Drugs Market Share by Region (2016-2027)
Figure 38. China Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Respiratory Disorders Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Respiratory Disorders Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Respiratory Disorders Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Respiratory Disorders Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Respiratory Disorders Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Respiratory Disorders Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Respiratory Disorders Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 58. Sanofi Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 60. Merck & Co. Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 61. Sumitomo Dainippon Pharma Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 64. Boehringer Ingelheim International Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 65. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Respiratory Disorders Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の呼吸器ウイルス感染症治療薬市場規模・現状・予測（2021年-2027年） North America dominated the global respiratory virus infection drugs market in 2019. The trend is anticipated to continue during the forecast period. Strategies adopted by key players, such as product approvals & launch and mergers & acquisitions, well-established healthcare infrastructure, and earl…- 世界の造血系疾患用治療薬・診断市場規模・現状・予測（2021年-2027年） Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood. Some blood disorders result in the increase of the number of cells in blood such as anemia, leukopenia while other cause the number of blood cell…
- 世界の骨髄増殖性疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Myeloproliferative Disorders Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の筋骨格系障害治療市場規模・現状・予測（2021年-2027年） Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon Market Analysis and Insights: G…
- 世界の下気道感染症治療市場規模・現状・予測（2021年-2027年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…